Full text
Earnings transcript
Read the complete earnings call transcript.
CNS
Cohen & Steers, Inc.
$62.66
0.53
(0.85%)
| Exchange: | NYSE |
| Market Cap: | 3.22B |
| Shares Outstanding: | 26.45M |
About The Company
| Sector: | Financial Services | |||||
| Industry: | Asset Management | |||||
| CEO: | Joseph Martin Harvey | |||||
| Full Time Employees: | 411 | |||||
| Address: |
| |||||
| Website: | https://www.cohenandsteers.com |
Cohen & Steers, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to institutional investors, including pension funds, endowments, and foundations. It manages separate client-focused equity, fixed income, multi-asset, and commodity portfolios through its subsidiaries. The firm launches and manages equity, fixed income, balanced, and multi-asset mutual funds through its subsidiaries. Through its subsidiaries, it also launches and manages hedge funds. The firm invests in public equity, fixed income, and commodity markets across the globe through its subsidiaries. Through its subsidiaries, it invests in companies operating in the real estate sector, including real estate investment trusts, infrastructure sector, and natural energy resources sector for its equity and fixed income investments. The firm also invests in preferred securities for its fixed income investments through its subsidiaries. Cohen & Steers, Inc. was founded in 1986 and is based in New York, with additional offices in London, United Kingdom; Central, Hong Kong; Tokyo, Japan; and Seattle, Washington.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 489,637 | 517,417 | 567,802 |
| Gross Profit | 235,286 | 242,300 | 326,518 |
| EBITDA | 169,619 | 203,390 | 200,444 |
| Operating Income | 164,477 | 172,877 | 177,736 |
| Net Income | 129,049 | 151,265 | 153,217 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 736,554 | 812,366 | 876,694 |
| Total Liabilities | 243,907 | 237,463 | 242,846 |
| Total Stockholders Equity | 381,228 | 511,711 | 561,953 |
| Total Debt | 140,408 | 141,115 | 0 |
| Cash and Cash Equivalents | 187,442 | 182,974 | 145,452 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 171,961 | 96,689 | -120,444 |
| Capital Expenditure | -56,986 | -11,651 | -5,979 |
| Free Cash Flow | 114,975 | 85,038 | -126,423 |
| Net Income | 129,049 | 162,792 | 144,865 |
| Net Change in Cash | -59,111 | -6,441 | -36,558 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2028 | Full Access | Full Access | Full Access | Full Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 534,179.180 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (High) | 569,050.821 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (Avg) | 551,615 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Low) | 210,367.956 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (High) | 224,100.943 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Avg) | 217,234.449 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Low) | 192,126.517 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (High) | 208,592.129 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Avg) | 200,359.323 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Low) | 59,373.382 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (High) | 63,249.324 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Avg) | 61,311.353 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Avg) | 3.880 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (High) | 4.040 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Low) | 3.720 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated Revenue) | 1 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated EPS) | 1 | Full Access | Full Access | Full Access | Full Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Solid Financial Performance: Cohen & Steers reported earnings of $0.73 per share in Q2 2025, reflecting consistent profitability as highlighted in the latest earnings call. Strong revenue and net income figures from income statements further support a robust financial position.
- Strong Investment Performance: The earnings call emphasized exceptional investment results despite a challenging market environment, indicating effective portfolio management and resilience in asset management strategies.
- Positive Free Cash Flow: Cash flow statements show healthy free cash flow, underpinned by strong operating cash flow, which provides financial flexibility for reinvestment or shareholder returns.
- Strategic Positioning: The company’s focus on niche areas within asset management, as per the company profile, and its strategic initiatives like active ETFs, position it well within the industry for sustained growth.
Log in with Full Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates CNS intrinsic value between $24.56 – $62.82 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
Common questions about CNS valuation
Is Cohen & Steers, Inc. (CNS) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for Cohen & Steers, Inc. (CNS) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is CNS a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether CNS trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is CNS’s P/E ratio?
You can see CNS’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for CNS?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is CNS a good long-term investment?
Whether CNS fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
CNS
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
0.85
Trading Metrics:
| Open: | 61.35 | Previous Close: | 62.13 | |
| Day Low: | 60.5 | Day High: | 62.68 | |
| Year Low: | 58.39 | Year High: | 83.99 | |
| Price Avg 50: | 64.49 | Price Avg 200: | 68.2 | |
| Volume: | 191556 | Average Volume: | 360145 |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's freeCNS full analysis
Welcome to MARKETSNAP’s SWOT analysis for Cohen & Steers, a name you might not hear every day in casual conversation but one that’s carving out a solid spot in the investment management space. Today, we’re diving deep into what makes this company tick, breaking down their strengths, weaknesses, opportunities, and threats with a long-term investor’s lens. Whether you’re looking to build wealth over decades or just curious about the short-term moves, I’ve got you covered with insights straight from the…
